Sproll Patrick, Eid Wassim, Gomes Camila R, Mendonca Berenice B, Gomes Nathalia L, Costa Elaine M-F, Biason-Lauber Anna
Division of Endocrinology, University of Fribourg, Fribourg, Switzerland.
Department of Biochemistry, Medical Research Institute, University of Alexandria, Alexandria, Egypt.
Mol Genet Genomic Med. 2018 Sep;6(5):785-795. doi: 10.1002/mgg3.445. Epub 2018 Jul 11.
One of the defining moments of human life occurs early during embryonic development, when individuals sexually differentiate into either male or female. Perturbation of this process can lead to disorders/differences of sex development (DSD). Chromobox protein homolog 2 (CBX2) has two distinct isoforms, CBX2.1 and CBX2.2: the role of CBX2.1 in DSD has been previously established, yet to date the function of the smaller isoform CBX2.2 remains unknown.
The genomic DNA of two 46,XY DSD patients was analysed using whole exome sequencing. Furthermore, protein/DNA interaction studies were performed using DNA adenine methyltransferase identification (DamID) to identify putative binding partners of CBX2. Finally, in vitro functional studies were used to elucidate the effect of wild-type and variant CBX2.2 on selected downstream targets.
Here, we describe two patients with features of DSD i.e. atypical external genitalia, perineal hypospadias and no palpable gonads, each patient carrying a distinct CBX2.2 variant, p.Cys132Arg (c.394T>C) and p.Cys154fs (c.460delT). We show that both CBX2.2 variants fail to regulate the expression of genes essential for sexual development, leading to a severe 46,XY DSD defect, likely because of a defective expression of EMX2 in the developing gonad.
Our study indicates a distinct function of the shorter form of CBX2 and by identifying several of its unique targets, can advance our understanding of DSD pathogenesis and ultimately DSD diagnosis and management.
人类生命的一个决定性时刻发生在胚胎发育早期,此时个体在性别上分化为男性或女性。这个过程的紊乱会导致性发育障碍/差异(DSD)。染色体盒蛋白同源物2(CBX2)有两种不同的异构体,CBX2.1和CBX2.2:CBX2.1在DSD中的作用此前已得到证实,但迄今为止,较小的异构体CBX2.2的功能仍不清楚。
使用全外显子组测序分析了两名46,XY DSD患者的基因组DNA。此外,使用DNA腺嘌呤甲基转移酶识别(DamID)进行蛋白质/DNA相互作用研究,以鉴定CBX2的假定结合伙伴。最后,进行体外功能研究以阐明野生型和变异型CBX2.2对选定下游靶点的影响。
在此,我们描述了两名具有DSD特征的患者,即非典型外生殖器、会阴型尿道下裂且未触及性腺,每名患者携带一种独特的CBX2.2变异体,p.Cys132Arg(c.394T>C)和p.Cys154fs(c.460delT)。我们表明,两种CBX2.2变异体均无法调节性发育所必需基因的表达,导致严重的46,XY DSD缺陷,这可能是由于发育中的性腺中EMX2表达缺陷所致。
我们的研究表明了CBX2较短形式的独特功能,并通过鉴定其几个独特靶点,能够增进我们对DSD发病机制的理解,并最终推动DSD的诊断和管理。